Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
TDP1 protein | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
AR protein | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
progesterone receptor | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
estrogen nuclear receptor alpha | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
polyprotein | 1 | 0 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
caspase-3 | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Histone H2A.x | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
geminin | 2 | 0 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 1 | 0 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 4 | 1 | 5 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |